Louis A. Matis

2019

In 2019, Louis A. Matis earned a total compensation of $759K as Chief Development Officer at Pieris Pharmaceuticals, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$130,776
Option Awards$207,137
Salary$403,631
Other$17,477
Total$759,021

Matis received $403.6K in salary, accounting for 53% of the total pay in 2019.

Matis also received $130.8K in non-equity incentive plan, $207.1K in option awards and $17.5K in other compensation.

Rankings

In 2019, Louis A. Matis' compensation ranked 10,425th out of 13,971 executives tracked by ExecPay. In other words, Matis earned more than 25.4% of executives.

ClassificationRankingPercentile
All
10,425
out of 13,971
25th
Division
Manufacturing
4,216
out of 5,701
26th
Major group
Chemicals And Allied Products
1,630
out of 2,200
26th
Industry group
Drugs
1,398
out of 1,886
26th
Industry
Pharmaceutical Preparations
1,037
out of 1,398
26th
Source: SEC filing on April 28, 2020.

Matis' colleagues

We found two more compensation records of executives who worked with Louis A. Matis at Pieris Pharmaceuticals in 2019.

2019

Stephen Yoder

Pieris Pharmaceuticals

Chief Executive Officer

2019

Hitto Kaufmann

Pieris Pharmaceuticals

Chief Scientific Officer

News

You may also like